[DOI] [PubMed] [Google Scholar] 291.Minuz P, Patrignani P, Gaino S, Seta F, Capone ML, Tacconelli S, et al
Performance & Recovery Support Supports sustained energy output and recovery efficiency in performance- and endurance-focused research contexts
Same hands
doi:10.1111/dom.13597 Funch D, Mortimer K, Ziyadeh NJ, J DS, Zhou L, Ng E, et al
North America is the leading regional market primarily because of the rising prevalence of obesity and Type 2 diabetes in this region
Clinical Development Program of Lixisenatide Phase II Dose-Finding Study The doseresponse effect of lixisenatide was evaluated in a large group ( n = 542) of metformin-treated patients with type 2 diabetes using OD or twice-daily (BD) lixisenatide regimens (530 g OD or BD) [10]